Wilmington-based Charles River Laboratories International Inc. said it has a deal with AstraZeneca PLC to perform early-stage experimental drug testing for the giant drug company before the products move to clinical trials. Charles River provides products and services to help pharmaceutical firms, government agencies, and academic institutions accelerate research and drug development efforts. Charles River said the three-year pact runs into 2015. Financial details weren’t disclosed.
Charles River Labs in deal with AstraZeneca
You've reached the limit of 10 free articles a month
Stay informed with unlimited access to Boston’s trusted news source.
- High-quality journalism from the region’s largest newsroom
- Convenient access across all of your devices
- Today’s Headlines daily newsletter
- Subscriber-only access to exclusive offers, events, contests, eBooks, and more
- Less than $1 a week